Watrium invests to become a shareholder of Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer. Its leading product is UV1, a therapeutic cancer vaccine directed against human telomerase. Watrium’s...
28th October 2015
Watrium invests in a 20 percent ownership share in Fornebu Gateway AS, which owns two ultra-modern office buildings at Fornebu outside Oslo. The buildings have lease contract durations of around...
